Ekso Bionics

Berkeley Exotech

Brief Description

Since 2005, Ekso Bionics has used exoskeleton technology to enhance natural abilities and improve quality of life. The exoskeleton industry leader, offering technologies that help those with paralysis to stand up and walk, enhancing worker capabilities globally, and providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities.

Formerly known as Berkeley Bionics and Berkeley Exotech.


  • 2005. Company founded
  • 2014. The company acquired PN Med Group Inc. through a reverse merger, resulting in the combined entity trading on the OTC Stock Exchange under the ticker symbol EKSO.


Russdon Angold, Andrew Chu, Nathan Harding, Homayoon Kazerooni, Jean-Louis Racine, Adam Zoss